Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program Mahaffey, K. W., Neal, B., Perkovic, V., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Sun, T., Desai, M., Matthews, D. R., CANVAS Program Collaborative Grp LIPPINCOTT WILLIAMS & WILKINS. 2017: E454–E455

View details for Web of Science ID 000417682700015